Clinical Trial Update: Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating rivaroxaban on top of aspirin for intracranial atherosclerotic stenosis, currently in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Arterial Stenosis
• Intracranial Atherosclerosis
• Stroke

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Ischemic Stroke, Intracranial Atherosclerosis | Phase 2, Phase 3 | Status: UNKNOWN